Mumbai: Lupin Limited has announced the launch of Topiramate Extended-Release Capsules in the United States after receiving approval for its Abbreviated New Drug Application (ANDA) from the US ...

Lupin has launched Topiramate Extended-Release capsules, in different strengths, in the United States. Bioequivalent to Supernus Pharmaceuticals’ Trokendi XR capsules and indicated for the treatment ...

Topiramate ER capsules had a market value of roughly $164 million, per IQVIA Dec 2025 data. The company is set to launch a lineup of specialty medications and generic oncology products, with plans to ...

MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 /PRNewswire/ — Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of ...

Drug firm Lupin Ltd on Wednesday (February 4) announced the launch of Topiramate extended-release capsules in the United States in 25 mg, 50 mg, 100 mg, and 200 mg strengths, following approval of its ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...